07 08 2015

JenaValve Receives $26.5 Million Financing
Proceeds to Enable Clinical Studies and Commercial Development of Innovative TAVR Systems Targeting Broad Patient Population

JenaValve Technology, Inc., a developer, manufacturer and marketer of next-generation transcatheter aortic valve repair (TAVR) systems for the treatment of aortic valve disease, today announced the successful completion of a $26.5 million Series C expansion round of financing. Proceeds from the financing will be used to support the Company’s...

LOGIN
To read the entire article, you must be a registered user.
Click here to register for free now, or fill out the form below to log in

Email:

Password:

Forgot password?

LATEST ISSUE
Powered by Share Trading

POPULAR ARTICLES
SEASIF Holding is Expecting Consolidated Corporate Earnings to Reach almost €1 Billion

09/05/2018

Seasif Holding is an international “conglomerate” headquartered in Cyprus;

How Britain Could Change Its Mind About Brexit

14/04/2018

Nigel Farage, the former UK Independence Party leader, now says that the June 2016 Br

The World Economy in 2018

14/04/2018

In the tenth year since the start of the global financial crisis, the US economy reac

Global Ambitions for US Specialty Food

13/04/2018

SAN FRANCISCO — With over 1,400 exhibitors and over 25,000 visitors, the Winter

Learning through Innovation

12/04/2018

CIVITANOVA MARCHE-Amicucci Formazione is a family-owned business leader in the provisio